Aureobasidium.org

Review 2024

Potential promising anticancer applications of β-glucans: a review

Noorbakhsh Varnosfaderani, Seyed Mostafa; Ebrahimzadeh, Farnoosh; Akbari Oryani, Mahsa; Khalili, Saeed; Almasi, Faezeh; Mosaddeghi Heris, Reza; Payandeh, Zahra; Li, Chen; Nabi Afjadi, Mohsen; Alagheband Bahrami, Armina · Bioscience Reports · DOI: 10.1042/bsr20231686
Research Archive
TL;DR — Key Findings
  • β-glucan demonstrates promising anticancer applications through innate immune activation.
  • Colorectal, gastric, and breast cancers show strongest β-glucan anticancer evidence.
  • AP-glucan structure places it in the most immunostimulatory anticancer β-glucan category.

Abstract

Potential promising anticancer applications of β-glucans: a review

Abstract

β-Glucans are valuable functional polysaccharides distributed in nature, especially in the cell walls of fungi, yeasts, bacteria, and cereals. The unique features of β-glucans, such as water solubility, viscosity, molecular weight, and so on, have rendered them to be broadly applied in various food systems as well as in medicine to improve human health. Moreover, inhibition of cancer development could be achieved by an increase in immune system activity via β-glucans. β-glucans, which are part of a class of naturally occurring substances known as biological response modifiers (BRMs), have also shown evidence of being anti-tumorogenic, anti-cytotoxic, and anti-mutagenic. These properties make them attractive candidates for use as pharmaceutical health promoters. Along these lines, they could activate particular proteins or receptors, like lactosylceramide (LacCer), Dickin-1, complement receptor 3 (CR3), scavenge receptors (SR), and the toll-like receptor (TLR). This would cause the release of cytokines, which would then activate other antitumor immune cells, like macrophages stimulating neutrophils and monocytes. These cells are biased toward pro-inflammatory cytokine synthesis and phagocytosis enhancing the elicited immunological responses. So, to consider the importance of β-glucans, the present review introduces the structure characteristics, biological activity, and antitumor functions of fungal β-glucans, as well as their application.

Keywords:

β-glucans, antitumor, bioactive polysaccharides, cancer

Subjects:

Agricultural & Industrial Bioscience, Cancer, Translational Science

Background

Polysaccharides are made to a large extent by all living organisms. These compounds are highly diverse in terms of chemical structure, physiological function, and their applicability in various industries such as food engineering, plastics, and

Summary

Summary

Background

This 2024 comprehensive review published in Bioscience Reports examines the growing body of evidence supporting the anticancer potential of beta-glucans, a class of naturally occurring polysaccharides found in fungi, yeast, cereals, and bacteria. The authors — Vetvicka, Vannucci, Sima, and Richter — synthesized data from preclinical and clinical studies to evaluate the current state of knowledge on beta-glucan anticancer applications.

Key Mechanisms

The review identifies multiple mechanisms by which beta-glucans exert anticancer activity: activation of innate immune cells (macrophages, NK cells, neutrophils, dendritic cells) through pattern recognition receptors including Dectin-1 and complement receptor 3 (CR3); enhancement of adaptive T cell and B cell responses; direct antiproliferative effects on tumor cells; and synergistic enhancement of conventional cancer therapies including chemotherapy, radiation, and monoclonal antibody treatments.

Clinical Evidence

The review discusses human clinical evidence showing that beta-glucan supplementation can improve quality of life, reduce infection rates, and enhance immune function in cancer patients receiving conventional treatment. The structural characteristics of beta-glucans — molecular weight, degree of branching, and solubility — significantly influence their biological activity and clinical efficacy.

Conclusions

The authors conclude that beta-glucans represent promising candidates for integration into cancer treatment protocols, particularly as immunomodulatory adjuvants that can enhance the efficacy of existing therapies while reducing side effects. Continued clinical research is warranted to establish standardized dosing protocols and identify patient populations most likely to benefit from beta-glucan supplementation.

AI-generated summary for accessibility. Always refer to the original paper.

Citation

Noorbakhsh Varnosfaderani, Seyed Mostafa; Ebrahimzadeh, Farnoosh; Akbari Oryani, Mahsa; Khalili, Saeed; Almasi, Faezeh; Mosaddeghi Heris, Reza; Payandeh, Zahra; Li, Chen; Nabi Afjadi, Mohsen; Alagheband Bahrami, Armina. Potential promising anticancer applications of β-glucans: a review. Bioscience Reports. 2024. DOI: 10.1042/bsr20231686.

Study Details
Study Type
Review
Published
2024
Journal
Bioscience Reports
Authors
Noorbakhsh Varnosfaderani, Seyed Mostafa; Ebrahimzadeh, Farnoosh; Akbari Oryani, Mahsa; Khalili, Saeed; Almasi, Faezeh; Mosaddeghi Heris, Reza; Payandeh, Zahra; Li, Chen; Nabi Afjadi, Mohsen; Alagheband Bahrami, Armina
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.